Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19"

被引：0
作者：
Solerte, Sebastiano Bruno [1 ,2 ]
D'Addio, Francesca [3 ]
Fiorina, Paolo [3 ,4 ,5 ]
机构：
[1] Univ Pavia, Dept Internal Med, Geriatr & Diabetol Unit, Pavia, Italy
[2] Univ Pavia ASP Pavia, Sch Geriatr, Pavia, Italy
[3] Univ Milan, Int Ctr T1D, Pediat Clin Res Ctr Romeo Enrica Invernizzi, DIBIC L Sacco, Milan, Italy
[4] ASST Fatebenefratelli Sacco, Div Endocrinol, Milan, Italy
[5] Harvard Med Sch, Boston Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA
来源：
ACTA DIABETOLOGICA | 2021年 / 58卷 / 02期
关键词：
D O I：
10.1007/s00592-020-01630-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：247 / 248
页数：2
相关论文
共 5 条
  • [1] Chia Siang Kow SSH, ACTA DIABETOL
  • [2] Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
    Green, Jennifer B.
    Bethel, M. Angelyn
    Armstrong, Paul W.
    Buse, John B.
    Engel, Samuel S.
    Garg, Jyotsna
    Josse, Robert
    Kaufman, Keith D.
    Koglin, Joerg
    Korn, Scott
    Lachin, John M.
    McGuire, Darren K.
    Pencina, Michael J.
    Standl, Eberhard
    Stein, Peter P.
    Suryawanshi, Shailaja
    Van de Werf, Frans
    Peterson, Eric D.
    Holman, Rury R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03) : 232 - 242
  • [3] Solerte SB, 2020, DIABETES CARE
  • [4] Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
    Solerte, Sebastiano Bruno
    Di Sabatino, Antonio
    Galli, Massimo
    Fiorina, Paolo
    [J]. ACTA DIABETOLOGICA, 2020, 57 (07) : 779 - 783
  • [5] DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
    Valencia, Ines
    Peiro, Concepcion
    Lorenzo, Oscar
    Sanchez-Ferrer, Carlos F.
    Eckel, Jurgen
    Romacho, Tania
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
1